Skip to content

Clinical and genetic findings in Parkinson’s disease in a Turkish cohort: a retrospective exome sequencing study

Sep 2026 · Neurogenetics · Vol 27 · 0 citations · 23 references
Medicine

TL;DR

The characterization of prominent VUS in OMIM-associated genes and a novel LRRK2 structural variant undetected by routine MLPA highlights the evolving complexity of PD genetics and the critical need for integrating comprehensive, read-depth-based CNV analysis into standard pipelines.

View source

Similar papers

Sep 2026

Exploring the genetic spectrum of parkinsonism in Brazil.

WES proved valuable in detecting rare pathogenic variants in Brazilian patients, uncovering atypical phenotypes and expanding the spectrum of genetic findings, highlighting the need for broader genetic studies in admixed populations to refine diagnostics and better characterize such unique cohorts.

M. G. Ferreira, C. Tesson, T. Courtin et al. · 0 citations
Open access Sep 2026

Genomic Landscape of Early-Onset and Familial Latin American Parkinson’s Patients

By expanding the reported spectrum of disease-associated variants in a Latin American population, this work identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin Am...

E. Waldo, H. M. Chaparro-Solano, M. Isayan et al. · 0 citations
Aug 2026

GCH1 genetic variation as a prognostic factor in Parkinson disease across populations

GCH1 pathogenic variants were associated with a clinically distinct phenotype characterized by earlier disease onset and slower progression of motor complications, suggesting that GCH1 genetic variants may serve as genetic biomarkers for patient stratification and prognosis in PD.

J. Shin, M. T. Periñán, J. W. Jang et al. · 0 citations
Open access Aug 2026

Clinical and Genetic Spectrum of ATP1A3-Related Disorders

The results highlight the need for a unified diagnostic framework for ATP1A3-related disorders and demonstrate the feasibility and scientific value of coordinated rare disease research in resource-limited settings.

Victor Rebelo Procaci, Raphael Pinheiro Camurugy da Hora, Anna Maria Gomes et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.